Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, March 1998, p. 186-191, Vol. 5, No. 2
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Immunodepression Induced by Trypanosoma
cruzi and Mouse Hepatitis Virus Type 3 Is Associated with
Thymus Apoptosis
Liana
Verinaud,1
Maria Alice
Da Cruz-Höfling,2
Júlia K.
Sakurada,1
Humberto A.
Rangel,1
José
Vassallo,3
Derek
Wakelin,4
Herb F.
Sewell,5 and
Irineu
J. B.
Camargo1,*
Department of Microbiology and
Immunology1 and
Department of Histology
and Embryology,2 Institute of Biology, and
Department of Pathology, Faculty of Medical
Sciences,3 UNICAMP, Campinas, Brazil, and
Department of Life Science4 and
Division of Molecular and Clinical
Immunology,5 Faculty of Medicine and Health
Sciences, Nottingham, United Kingdom
Received 17 September 1997/Returned for modification 29 October
1997/Accepted 5 December 1997
 |
ABSTRACT |
Trypanosoma cruzi-infected mice show disturbance in the
peripheral immune system such as polyclonal lymphocyte activation, autoantibody production, and immunosuppression of T lymphocytes. Previous observations in our laboratory showed that some stocks of
T. cruzi can be contaminated with mouse hepatitis virus
type 3 (MHV-3). Literature has shown that MHV-3 infection induces
immunologic disorders characterized by thymic involution with marked
cell depletion. However, the effects of interactions between MHV-3 and
the parasite on the immune system are not well understood. In the
present study specific-pathogen-free CBA mice were inoculated with
MHV-3, alone or associated with different stocks of T. cruzi. Concurrent murine virus infection resulted in increased
pathogenicity of T. cruzi infection shown by profound
thymic atrophy; loss of cortical thymocytes; depletion of
Thy1.2+, CD4+, and CD8+ cells;
enhancement of in situ labeling of nuclear DNA fragmentation; and
eventually, death of the animals. Such lines of evidence show that the
mechanism underlying this thymic atrophy is associated with apoptosis.
These results also suggest that MHV-3 can account for the increased
immunosuppression observed during experimental infection with the
parasite.
 |
INTRODUCTION |
Chagas' disease, caused by the
protozoan Trypanosoma cruzi, afflicts about 18 million
people on the American continent (29). Although the disease
has been extensively studied, its pathogenesis is far from completely
elucidated. Results obtained by using mice as an experimental model
indicate that the outcome of infection is determined by many different
factors. These include the genetic backgrounds of both the host
(19, 26, 30) and the parasite (7, 18) and the
experimental conditions under which infections are carried out
(4). The role of concurrent infections in influencing the
pathogenesis of T. cruzi has not been defined, although it is well known that such infections may seriously compromise host resistance. For example, endogenous viral infections alter host responsiveness through their multiple immunomodulatory effects (3,
6, 8, 9).
Recently, we have shown that specific-pathogen-free CBA/J mice infected
with the Y strain of T. cruzi, which is maintained by serial
mouse passage of YUEC stock, had higher levels of
parasitemia and shorter survival times than animals infected with a
stock of parasites (YCT) which was maintained exclusively
in cell culture. Tests for virus-specific antibody using filtered
plasma from YUEC-infected animals indicated the presence in
these animals of murine hepatitis virus type 3 (MHV-3) (20).
The cultures in which YCT is maintained are virus free, and
thus, mice infected with this strain did not acquire the virus. Both
MHV-3- and YUEC-infected animals show a marked lymphopenia
in peripheral blood as early as 48 h postinfection (p.i.), whereas
this does not occur in YCT-infected animals
(27).
These data suggest that the greater pathology shown by
YUEC-infected animals results from combination of viral and
protozoal infection and is correlated with the observed lymphopenia. To investigate this point, changes in the cellularity and structure of the
thymus were monitored in four groups
mice infected with MHV-3 alone,
mice infected with YUEC, mice infected with
YCT, and mice double infected with MHV-3 and
YCT
and these were compared with uninfected controls. In
each group, total thymus cell numbers; percentages of Thy1.2,
CD4+, and CD8+ cells; thymus weight; and
histological changes were quantified during the course of infection. In
addition, in order to clarify points related to the biological
significance of the observed lymphopenia, we investigated whether
cortical thymocytes in infected mice undergo DNA fragmentation
(apoptosis). A demonstration of apoptosis should provide clues for
understanding how concurrent infection might be associated with reduced
host resistance.
 |
MATERIALS AND METHODS |
Animals.
CBA/J (8- to 10-week-old) mice of both sexes were
obtained from specific-pathogen-free colonies bred in isolators at
Centro Multi-Institucional de Bioterismo, Unicamp. These colonies have been periodically screened since 1989 with consistently negative results for the following microorganisms: MHV-3, Sendai virus, lymphocytic choriomeningitis virus, rotavirus, pneumonia virus of mice,
reovirus 3, Theiler's GD-VII virus, mouse minute virus, K virus,
ectromelia virus, mouse adenovirus, mouse cytomegalovirus, and lactate
dehydrogenase-elevating virus; Mycoplasma pulmonis; pathogenic bacteria; ectoparasites; and endoparasites. The animals were
maintained in plastic isolators under aseptic conditions throughout the
study.
Parasites.
Two different stocks of the Y strain of T. cruzi were used. The stock originally received from Z. Brener in
1972 was labelled YUEC and is maintained in CBA/J mice by
infecting animals, every week, with 105 blood parasites
intraperitoneally. The stock YCT was obtained by culturing
YUEC parasites in monolayers of LLC-MK2 cells
as reported earlier (5). This parasite stock produces an
active infection when injected in mice, as indicated by the presence of
parasitemia that peaked on the 7th day p.i., but was unable to kill
CBA/J mice when 105 parasites were injected subcutaneously.
Virus.
MHV-3 isolated in our laboratory was used throughout
the experiments. MHV-3 was cultured in L-929 cells and stored in liquid nitrogen (14). The 50% lethal dose (LD50) of
the virus preparations was determined by the method of Reed and Muench
(22).
Experimental design.
Four experimental groups of 25 CBA/J
mice (total, 100 mice) were inoculated subcutaneously in the left hind
limb with (i) 105 trypomastigotes of the YCT
stock of T. cruzi, (ii) 105 trypomastigotes of
the YUEC stock of T. cruzi, (iii) 0.1 LD50 of coronavirus (MHV-3), and (iv) 105
trypomastigotes of the YCT stock plus 0.1 LD50
of MHV-3. Five mice in each group were sacrificed 1, 2, 3, 5, and 7 days post-inoculation, after which the thymuses were removed and
weighed. Single-cell suspensions were obtained from these organs by
gently teasing the tissue in RPMI 1640 medium. The cells thus obtained
were washed twice and resuspended in the same medium, their viability
was determined by the trypan blue exclusion test, and they were counted in a hemacytometer. Twenty-five mice were used as uninfected control group (normal group).
Histopathological study.
At sacrifice, thymuses were
collected and immediately fixed in buffered 10% formaldehyde fixative,
and then they were routinely processed and embedded in paraffin.
Sections (4 µm) for histological examination were stained with
hematoxylin-eosin and examined by light microscopy.
Lymphocyte subpopulation measurement.
Briefly, thymuses were
individually collected after sacrifice, and cells were obtained by
gently teasing with tweezers in RPMI 1640 medium. Cell suspensions were
adjusted to give desired cell concentrations (2 × 105/ml), laid in slides by centrifugation, air dried, fixed
in cold acetone, and subjected to indirect immunoperoxidase assays.
Endogenous peroxidase activity was abolished by immersing the slides
for 20 min in methanol containing 0.3% H2O2.
Different lymphocyte populations were identified by using a three-step
staining procedure. First, the cells were incubated with monoclonal
antibody (MAb) to T helper cells (GK 1.5 clone), MAb to T
suppressor/cytotoxic cells (YTS 169 clone), or MAb to total T cells
(Thy 1.2 antigen), followed by incubation with biotinylated goat
anti-rat immunoglobulin G (Dako A/S) and finally with avidin-peroxidase
complex (Vector Laboratories). The stain was developed by adding
3,3'-diaminobenzidine tetrahydrochloride (Sigma Chemical Co.) solution
containing 0.03% hydrogen peroxide and incubating for 20 min in
darkness. The slides were weakly counterstained with Mayer's
hematoxylin (Merck) and examined by light microscopy. Cells showing
positive staining were identified by the peripheral rim of brown color
outlining the cell membrane. The percentage of positive cells was
scored quantitatively by counting 100 cells in five microscopic fields and by two independent investigators.
In situ identification of nuclear DNA fragmentation.
Tissue
sections were analyzed by in situ end labelling of fragmented DNA as
previously described (28). Briefly, after a 10%
formaldehyde fixation, thymuses from infected and control mice were
paraffin embedded. Sections were treated with proteinase K solution and
washed with phosphate-buffered saline, and residues of
digoxigenin-nucleotide were catalytically added to the DNA by terminal
deoxynucleotidyl transferase. Antidigoxygenin antibodies labelled with
peroxidase (ApopTag-Oncor) were used to detect the reaction. Staining
was developed in diaminobenzidine-H2O2, and sections were counterstained with Harris hematoxylin.
Statistical analysis.
Student's t test was used
as described by Zar (31).
 |
RESULTS |
Thymus weight and cellularity were strikingly diminished in mice
infected intraperitoneally with MHV-3, with the YUEC stock of T. cruzi, or with YCT plus MHV-3.
Figure 1A shows that the only group able
to maintain thymic weight was that infected with the avirulent stock of
parasites (YCT). All other groups that were infected with
MHV-3, alone or associated with parasites, showed a marked decrease in
thymic weight. The atrophy started 24 to 48 h p.i. and on day
7 p.i. represented approximately 50% of thymic weight in normal
uninfected animals or the YCT-infected group.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Thymic alterations during MHV-3, YCT,
YUEC, and YCT-MHV-3 infection of animals.
Weight (A) and cellularity (B) are dramatically diminished in groups
infected with MHV-3, the YUEC stock of parasites, and
YCT plus MHV-3 but remain stable in animals infected only
with the YCT stock of parasites. The values for each day
are means with standard deviations for experiments involving five mice
analyzed individually. Normal levels in uninfected animals are
delineated by horizontal lines.
|
|
As shown in Figure 1B, numbers of thymic cells decreased in
MHV-3-infected animals as early as 24 h p.i. until day 3 p.i., when numbers showed some recovery. Moreover, these animals were able to survive for more than 30 days after infection.
YUEC- and YCT-MHV-3-infected mice showed
thymic cell depletion around 48 and 72 h p.i., respectively, and
numbers continued to fall until the animals died. No significant
differences were observed in the numbers of thymic cells in
YCT-infected animals. Virus infection, alone or in
association with parasites, provoked significant decreases in the
percentages of Thy1.2+, CD4+, and
CD8+ cells in the thymus. This reduction in thymocyte
subpopulations started at 24 h p.i. and reached maximum values on
day 7 p.i. (Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Percentages of thymic cells expressing specific T-cell
markers in parasite- and/or MHV-3-infected mice on days 1 and 7 p.i.
|
|
Comparative histopathological studies of thymuses from stocks of
T. cruzi- and MHV-3-infected mice showed differences in
morphology and in the cortical/medullary content ratio. Thymus tissue
from YCT-infected mice (Fig.
2A) was similar to that from control mice (not shown). In contrast, animals infected with YCT plus
MHV-3 (Fig. 2B), MHV-3 alone (Fig. 2C), or YUEC stock (Fig.
2D) showed significant thinning and cellular depletion in the thymic
cortex and a decreased mitotic index (data not shown). Besides, these animals showed a "starry sky" pattern, caused probably by
interspersed histiocytes.

View larger version (162K):
[in this window]
[in a new window]
|
FIG. 2.
Histology of thymuses from YCT-infected
CBA/J mice (A), YCT-plus MHV-3-infected CBA/J mice (B),
MHV-3-infected CBA/J mice (C), and YUEC-infected CBA/J mice
(D). No alterations were observed in YCT-infected animals
compared with uninfected controls (data not shown). The other groups
showed dramatic depletion in the cortical zone. Hematoxylin-eosin
staining was used. Magnification, ×140.
|
|
In order to verify the origin of thymic atrophy and the fate of
subpopulations of thymocytes, we investigated the degree of programmed
cell death in tissue sections by in situ end labelling of fragmented
DNA. YCT-infected mice showed a few cells with fragmented DNA (Fig. 3A). In contrast, the number of
apoptotic cells in the thymuses of mice infected with YCT
plus MHV-3 (Fig. 3B) was dramatically increased. Thymuses of
MHV-3-infected animals (Fig. 3C) and those infected with the
YUEC stock of parasites (Fig. 3D) showed significant numbers of apoptotic cells, but these numbers were lower than those in
YCT- plus MHV-3-infected animals and only slightly higher than those in YCT-infected animals. In addition, different
patterns of DNA fragmentation were observed in different groups. While animals infected with the YCT or YUEC stock of
parasites (Fig. 3A and D) showed a round nuclear pattern, animals
infected with YCT plus MHV or MHV alone (Fig. 3B and C)
showed large clusters of irregular masses scattered in a disorganized
cortico-medullary region.

View larger version (164K):
[in this window]
[in a new window]
|
FIG. 3.
Apoptosis in a thymus section from a
YCT-infected animal (A), a YCT- plus
MHV-3-infected animal (B), a MHV-3-infected animal (C), and a
YUEC-infected animal (D). YCT-infected animals
showed rare apoptosis granules, whereas the animals infected with the
virus alone or in association with the parasite showed increased
numbers of apoptotic cells. Hematoxylin counterstaining was used.
Magnification, ×420.
|
|
 |
DISCUSSION |
Conventionally housed laboratory mice may sustain infections with
one or more murine virus (10). The method of breeding mice
under barrier-sustained conditions only recently became available to
some laboratories, and so, earlier isolates of T. cruzi were maintained in mice that were coinfected by other pathogens.
Here we have observed a marked thymic cell depletion when animals were
infected with MHV-3, alone or associated with one stock of the
parasite. The diminished cellularity in thymus correlated well with
decreased numbers of Thy1.2, CD4+, and CD8+
thymocyte subpopulations. These findings, showing that MHV-3 is able to
exacerbate the parasite infection, together with the observed effects
upon numbers of circulating lymphocytes (unpublished data) and thymic
cells, suggest that the enhanced pathology associated with
YUEC infection reflects underlying alterations in the
immune system. There are examples in the literature which show
aggravation of both T. cruzi and murine leukemia virus by
concomitant infections (25). It is known that MHV induces
lymphoid organ atrophy (15) and shows a tropism to T and B
lymphocytes (13). However, the mechanisms responsible for
immunodeficiency associated with MHV-3 infection remain unknown.
The present results suggest that virus-induced programmed cell death
could account for the loss of T lymphocytes from the thymuses observed
after either YCT plus MHV-3 or YUEC infection. Together with the inhibition of thymocyte mitotic index in these animals, cellular death by apoptosis would be responsible for the
thinning or atrophy of the thymus cortex. Apoptosis of T lymphocytes in
animals infected with T. cruzi has already been demonstrated in spleen CD4+ cells (16). Similarly, several
viruses, including some strains of MHV, are able to induce apoptosis
(11, 21, 24). The unchanged numbers of both peripheral
lymphocytes (unpublished data) and thymic cells, as well as the
maintenance of a normal cortical/medullary content ratio in
YCT-infected mice, are consistent with the low level of
programmed cell death in this group. On the other hand, the more
extensive apoptosis observed in the thymus in T. cruzi- plus
MHV-3-infected mice suggests a severe immunosuppression which is
probably triggered by the virus replication.
T-cell-dependent immune responses are crucial in the control of
T. cruzi infection (2, 17, 23). Cellular immune
responses mediated by helper and cytotoxic T lymphocytes are also
involved in the elimination of viral infection (13).
Therefore, control of both infections is dependent upon the capacity of
the thymus to generate and maintain normal T lymphopoiesis. In the
present work we have observed a marked thymic involution in animals
that were infected with the MHV-3 alone or with MHV-3 associated with T. cruzi, and this may well explain the greater pathology
seen in these mice.
Several mechanisms including secretion of different mediators
(1) could be responsible for the apoptosis seen during the course of the infections reported here. Further work is necessary to
determine whether this apoptosis occurs as a result of direct lymphocyte or stromal cell infection or is caused by stress-induced glucocorticoid release and/or secretion of other soluble factors from
intra- and extrathymic sites (12).
 |
ACKNOWLEDGMENTS |
This work was supported by grants from Fundo de Apoio ao Ensino e
Pesquisa/Unicamp and Fundação de Amparo à Pesquisa do Estado de São Paulo.
We thank Hélio Bezerra Coutinho and the staff of the Centro de
Pesquisa Aggeu Magalhães of the Instituto Oswaldo Cruz from Recife for support during the apoptosis study and M. C. Colombari from Unicamp and G. King from University of Aberdeen for skillful technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento de
Microbiologia e Imunologia, Instituto de Biologia/Unicamp, C.P. 6109, CEP 13083-970, Campinas, São Paulo, Brazil. E-mail:
barsanti{at}obelix.unicamp.br.
 |
REFERENCES |
| 1.
|
Aliprantis, A. O.,
G. Diez-Roux,
L. C. F. Mulder,
A. Zychlinsky, and R. A. Lang.
1996.
Do macrophages kill through apoptosis.
Immunol. Today
17:573-576[Medline].
|
| 2.
|
Araujo, F.
1989.
Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes.
Infect. Immun.
57:2246-2248[Abstract/Free Full Text].
|
| 3.
|
Boorman, G. A.,
M. L. Luster, and J. H. Dean.
1982.
Peritoneal macrophage alterations caused by naturally occurring mouse hepatitis virus.
Am. J. Pathol.
106:110-117[Abstract].
|
| 4.
|
Calabrese, K. S.,
P. G. Bauer,
P. H. Lagrange, and S. C. Gonçalves Costa.
1991.
Trypanosoma cruzi infection in immunosuppressed mice.
Immunol. Lett.
31:91-96.
|
| 5.
|
Camargo, I. J. B.,
J. K. Sakurada,
M. R. Zucato,
P. M. F. Araújo, and H. A. Rangel.
1989.
The early phase of immune response of CBA/J mice infected with Trypanosoma cruzi.
Immunol. Lett.
20:213-216[Medline].
|
| 6.
|
Casebolt, D. B.,
D. M. Spalding, and T. R. Schoeb.
1987.
Suppression of immune response induction in Peyer's patch lymphoid cells from mice infected with mouse hepatitis virus.
Cell. Immunol.
23:539-547.
|
| 7.
|
Celentano, A. M., and S. M. Gonzales Cappa.
1992.
Induction of macrophage activation and opsonizing antibodies by Trypanosoma cruzi subpopulations.
Parasite Immunol.
14:155-167[Medline].
|
| 8.
|
Dempsey, W. L.,
A. L. Smith, and P. S. Morahan.
1986.
Effect of inapparent murine hepatitis virus infections on macrophages and host resistance.
J. Leukocyte Biol.
39:559-565[Abstract].
|
| 9.
|
Dindzans, V. J.,
B. Zimmerman, and A. Sherker.
1987.
Susceptibility to mouse hepatitis virus-3 in BALB/c mice: failure of immune cell proliferation and interleukin 2 production.
Adv. Exp. Biol.
218:411-420[Medline].
|
| 10.
|
Gilioli, R.,
J. K. Sakurada,
L. A. G. Andrade,
V. Kraft,
B. Meyer, and H. A. Rangel.
1996.
Virus infection in rat and mouse colonies reared in Brazilian animal facilities.
Lab. Anim. Sci.
46:582-584[Medline].
|
| 11.
|
Godfraind, C.,
K. V. Holmes, and J. P. Coutelier.
1995.
Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.
J. Virol.
69:6541-6547[Abstract].
|
| 12.
|
Gruber, J.,
R. Sgonc,
Y. H. Hu,
H. Beug, and G. Wick.
1994.
Thymocyte apoptosis induced by elevated endogenous corticosterone levels.
Eur. J. Immunol.
24:1115-1121[Medline].
|
| 13.
|
Jolicouer, P., and L. Lamontagne.
1994.
Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3.
J. Immunol.
153:1318-1327[Abstract].
|
| 14.
|
Kraft, V., and B. Meyer.
1986.
Diagnosis of murine infections in relation to test methods employed.
Lab. Anim. Sci.
36:272-276.
|
| 15.
|
Lamontagne, L., and P. Jolicouer.
1994.
Low-virulent mouse hepatitis viruses exhibiting various tropisms in macrophages, T and B cell subpopulations and thymic stromal cells.
Lab. Anim. Sci.
44:17-24[Medline].
|
| 16.
|
Lopes, M. F.,
V. F. da Veiga,
A. R. Santos,
M. E. F. Fonseca, and G. A. DosReis.
1995.
Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
J. Immunol.
154:744-752[Abstract].
|
| 17.
|
Minóprio, P. M.
1991.
Chagas's disease: CD5 B cell dependent Th2 pathology?
Res. Immunol.
142:137-140[Medline].
|
| 18.
|
Muller, L. A.,
N. Añasco, and S. M. Gonzales-Cappa.
1986.
Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.
Exp. Parasitol.
61:284-293[Medline].
|
| 19.
|
Nogueira, N.,
J. Ellis,
S. Chaplan, and Z. Cohn.
1981.
Trypanosoma cruzi: in vivo and in vitro correlation between T-cell activation and susceptibility in inbred strains of mice.
Exp. Parasitol.
51:325-330[Medline].
|
| 20.
|
Rangel, H. A.,
L. Verinaud,
I. J. B. Camargo,
R. Gilioli, and J. Sakurada.
1994.
Murine virus contaminant of Trypanosoma cruzi experimental infection.
Rev. Inst. Med. Trop. São Paulo
36:423-431[Medline].
|
| 21.
|
Razvi, E. S., and M. Welsh.
1993.
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency.
J. Virol.
67:5754-5765[Abstract/Free Full Text].
|
| 22.
|
Reed, L. J., and H. Muench.
1938.
A simple method of estimating fifty percent end points.
Am. J. Hyg.
27:493-497.
|
| 23.
|
Rottenberg, M. E.,
M. Bakhiet,
T. Olsson,
K. Kristensson,
T. Mak,
H. Wigzell, and A. Örn.
1993.
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei.
Infect. Immun.
61:5129-5133[Abstract/Free Full Text].
|
| 24.
|
Saha, K.,
P. H. Yuen, and P. K. Y. Wong.
1994.
Murine retrovirus-induced depletion of T cells is mediated through activation-induced death by apoptosis.
J. Virol.
68:2735-2740[Abstract/Free Full Text].
|
| 25.
|
Silva, J. S.,
M. Barral-Neto, and S. G. Reed.
1994.
Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections.
Am. J. Trop. Med. Hyg.
49:589-597.
|
| 26.
|
Trischmann, T. M.
1986.
Trypanosoma cruzi: early parasite proliferation and host resistance in inbred strains of mice.
Exp. Parasitol.
62:194-201[Medline].
|
| 27.
|
Verinaud, L.
1996.
Alterações da resposta imune à infecção pelo Trypanosoma cruzi induzidas pela contaminação com um Coronavirus murino. Ph.D. thesis.
State University of Campinas, Campinas, Brazil.
|
| 28.
|
Wijsman, J. H.,
R. R. Jonker,
R. Keijzer,
C. J. H. van de Velde,
C. J. Cornelisse, and J. H. van Dierendonck.
1993.
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.
J. Histochem. Cytochem.
41:7-12[Abstract].
|
| 29.
|
World Health Organization.
1991.
Control of Chagas's disease.
Bull. W. H. O.
187:1.
|
| 30.
|
Wrightsmann, R.,
S. Krassner, and J. Watson.
1982.
Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival.
Infect. Immun.
36:637-644[Abstract/Free Full Text].
|
| 31.
|
Zar, J. H.
1984.
Biostatistical analysis, 2nd ed.
Prentice-Hall, Inc., Englewood Cliffs, N.J.
|
Clinical and Diagnostic Laboratory Immunology, March 1998, p. 186-191, Vol. 5, No. 2
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.